Jackson W F
Am J Physiol. 1986 Jun;250(6 Pt 2):H1102-8. doi: 10.1152/ajpheart.1986.250.6.H1102.
The hypothesis that prostaglandins mediate arteriolar O2 reactivity was tested by assessing the effects of cyclooxygenase and phospholipase A2 inhibitors on the O2 responses of arterioles in superfused hamster cheek pouch and hamster and rat cremaster muscle preparations by use of intravital microscopy. Superfusion of these three preparations with the cyclooxygenase inhibitor indomethacin (50 microM) completely inhibited the response of the vessels to exogenous arachidonic acid but had no effect on the arteriolar constriction induced by elevation of superfusion solution PO2 from 15 to 150 mmHg. Similar results were obtained in the hamster cheek pouch with another cyclooxygenase inhibitor, meclofenamate, or when indomethacin (5-50 mg/kg) was administered systemically. Dexamethasone (12.7 microM) and quinacrine (10 microM), two reported inhibitors of phospholipase A2, also had no significant effect on arteriolar O2 reactivity in the cheek pouch. At 50 microM, quinacrine significantly depressed arteriolar reactivity to O2, adenosine, methacholine, and phenylephrine, suggesting nonspecific effects. These data do not support the hypothesis that prostaglandins mediate arteriolar O2 reactivity.
通过使用活体显微镜评估环氧化酶和磷脂酶A2抑制剂对灌注的仓鼠颊囊以及仓鼠和大鼠提睾肌制备物中微动脉O2反应的影响,来检验前列腺素介导微动脉O2反应性的假说。用环氧化酶抑制剂吲哚美辛(50 microM)灌注这三种制备物,可完全抑制血管对外源性花生四烯酸的反应,但对因将灌注液PO2从15 mmHg升高至150 mmHg所诱导的微动脉收缩没有影响。在仓鼠颊囊中使用另一种环氧化酶抑制剂甲氯芬那酸,或全身给予吲哚美辛(5 - 50 mg/kg)时,也得到了类似的结果。已报道的两种磷脂酶A2抑制剂地塞米松(12.7 microM)和奎纳克林(10 microM),对颊囊中微动脉的O2反应性也没有显著影响。在50 microM时,奎纳克林显著降低了微动脉对O2、腺苷、乙酰甲胆碱和去氧肾上腺素的反应性,提示存在非特异性作用。这些数据不支持前列腺素介导微动脉O2反应性的假说。